Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Amneal Pharmaceuticals, Inc.

Cost Efficiency Showdown: Dr. Reddy's vs. Amneal

__timestampAmneal Pharmaceuticals, Inc.Dr. Reddy's Laboratories Limited
Wednesday, January 1, 201433598900056369000000
Thursday, January 1, 201536705400062786000000
Friday, January 1, 201642077000062427000000
Sunday, January 1, 201750747600062453000000
Monday, January 1, 201894658800065724000000
Tuesday, January 1, 2019127337600070421000000
Wednesday, January 1, 2020136413000080591000000
Friday, January 1, 2021132469600086645000000
Saturday, January 1, 20221427596000100551000000
Sunday, January 1, 2023157304200042907000000
Monday, January 1, 2024115557000000
Loading chart...

Cracking the code

A Tale of Two Pharmaceutical Giants: Cost Efficiency Over Time

In the competitive world of pharmaceuticals, cost efficiency is a critical factor for success. This analysis compares the cost of revenue efficiency between Dr. Reddy's Laboratories Limited and Amneal Pharmaceuticals, Inc. from 2014 to 2023. Dr. Reddy's Laboratories consistently outperformed Amneal, with an average cost of revenue nearly 770% higher, reflecting its expansive operations and market reach. Notably, Dr. Reddy's saw a significant increase in 2022, reaching a peak of over 100 billion, while Amneal's costs rose steadily, peaking at 1.57 billion in 2023. The data for 2024 is incomplete, highlighting the dynamic nature of the industry. This comparison underscores the importance of strategic cost management in maintaining competitive advantage and profitability in the pharmaceutical sector.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025